- Report
- October 2024
- 191 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 288 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- September 2024
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 302 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 293 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 250 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- April 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2025
- 145 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 84 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- May 2024
- 120 Pages
Middle East, Africa
From €3280EUR$3,450USD£2,755GBP
- Report
- May 2024
- 87 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- May 2024
- 88 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2018
- 288 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- April 2023
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- May 2024
- 75 Pages
From €3280EUR$3,450USD£2,755GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more